Cognitive Impairment and MS: Searching for Effective Therapies Vijayshree YadavDennis N. Bourdette Clinical Trial Report 30 July 2011 Pages: 451 - 454
Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive Impairment Luis F. Gonzalez-CuyarJoshua A. SonnenThomas J. Montine ReviewPaper 05 July 2011 Pages: 455 - 463
Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases Irfan A. QureshiMark F. Mehler ReviewPaper 15 June 2011 Pages: 464 - 473
Cognitive Impairment in Huntington Disease: Diagnosis and Treatment Jane S. Paulsen ReviewPaper 23 August 2011 Pages: 474 - 483
Pharmacogenomics and Multiple Sclerosis: Moving Toward Individualized Medicine Manuel ComabellaKoen Vandenbroeck ReviewPaper 24 June 2011 Pages: 484 - 491
Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions Matthias MehlingLudwig KapposTobias Derfuss ReviewPaper 26 July 2011 Pages: 492 - 497
The Radiologically Isolated Syndrome: Look (Again) Before You Treat Rebecca SpainDennis Bourdette ReviewPaper 12 July 2011 Pages: 498 - 506
Gait Abnormalities in Multiple Sclerosis: Pathogenesis, Evaluation, and Advances in Treatment Michelle H. CameronJoanne M. Wagner ReviewPaper 22 July 2011 Pages: 507 - 515